title: From antilymphocyte serum to therapeutic monoclonal antibodies: first experiences with a chimeric CD4 antibody in the treatment of autoimmune disease.
authors: Institut für Immunologie, Universität München, Germany.
authors: G
authors: G
authors: Riethmüller
authors: E P
authors: EP
authors: Rieber
authors: S
authors: S
authors: Kiefersauer
authors: J
authors: J
authors: Prinz
authors: P
authors: P
authors: van der Lubbe
authors: B
authors: B
authors: Meiser
authors: F
authors: F
authors: Breedveld
authors: J
authors: J
authors: Eisenburg
authors: K
authors: K
authors: Krüger
authors: K
authors: K
authors: Deusch
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000628:therapy*; D015704:CD4 Antigens / Q000276:immunology*; D006801:Humans; D011993:Recombinant Fusion Proteins / Q000276:immunology / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D015704:CD4 Antigens; D011993:Recombinant Fusion Proteins